The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of the prognostic value of guanylyl cyclase C (GCC) lymph node (LN) classification in patients with stage II colon cancer: A pooled analysis.
Daniel J. Sargent
Research Funding - DiagnoCure; Signal Genetics
Qian Shi
No relevant relationships to disclose
Murray B. Resnick
Research Funding - DiagnoCure
Stephen Lyle
Research Funding - DiagnoCure
Michael O. Meyers
No relevant relationships to disclose
Atoussa Goldar-Najafi
Research Funding - DiagnoCure
Thomas E. Clancy
Research Funding - DiagnoCure
Sharlene Gill
Research Funding - DiagnoCure
Jean-Francois Haince
Employment or Leadership Position - DiagnoCure
Stock Ownership - DiagnoCure
Yves Fradet
Employment or Leadership Position - DiagnoCure
Stock Ownership - DiagnoCure